Dennis L. Confer

National Marrow Donor Program — United States

Medicine · Health Sciences

52h-index12.8kcitations235works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(153), Renal Transplantation Outcomes and Treatments(39), T-cell and B-cell Immunology(33), Acute Myeloid Leukemia Research(26), Acute Lymphoblastic Leukemia research(25)

Publications235 total

Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
UNC Libraries·2025Open Access
Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
UNC Libraries·2025Open Access
Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia
JCO Oncology Practice·2025
Donation-related decision-making among young adult Black and Hispanic members of a hematopoietic stem cell donor registry: A qualitative study
SSM - Qualitative Research in Health·2025Open Access
Factors Associated with Opting Out of an Unrelated Hematopoietic Stem Cell Donor Registry: Differences and Similarities across Five Key Groups of Young Race/Ethnically Diverse Potential Donors in the United States
Transplantation and Cellular Therapy·2024· 4 cited
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Transplantation and Cellular Therapy·2022· 50 citedOpen Access
Factors Associated with Opting Out of Donation among Registered Young Unrelated Hematopoietic Stem Cell Donors
Transplantation and Cellular Therapy·2022· 12 citedOpen Access
The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials
Transplantation and Cellular Therapy·2022· 9 citedOpen Access
Racial and Ethnic Differences in Attitudes, Perceptions, and Knowledge about Unrelated Hematopoietic Stem Cell Donation: A Study of Younger Newly Recruited Potential Donors
Transplantation and Cellular Therapy·2022· 13 citedOpen Access
The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Rdsafe and BMT CTN 0201
Blood·2021
Attitudes about Donating Stem Cells during COVID-19 among African American and Hispanic Members of an Unrelated Donor Registry
Transplantation and Cellular Therapy·2021· 3 citedOpen Access
National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Journal of Clinical Oncology·2021· 199 citedOpen Access
Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations
Transplantation and Cellular Therapy·2021· 4 citedOpen Access
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study
Transplantation and Cellular Therapy·2021· 3 citedOpen Access
Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative
Blood·2020· 7 cited
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers
UNC Libraries·2020Open Access
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre‐transplant minimal residual disease reduction
Pediatric Blood & Cancer·2020· 4 citedOpen Access
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study
Biology of Blood and Marrow Transplantation·2020· 11 citedOpen Access
Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
Bone Marrow Transplantation·2020Open Access
Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
Bone Marrow Transplantation·2020· 12 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Mary M. Horowitz(20), Claudio Anasetti(15), Brent R. Logan(15), Stephen R. Spellman(11), Daniel J. Weisdorf(10), Michael A. Pulsipher(10), Roberta King(10), Mary Eapen(9), Michelle Setterholm(9), Carolyn Katovich Hurley(8), Bronwen E. Shaw(8), Martin Maiers(7), Pintip Chitphakdithai(7), Marcelo Fernández-Viña(6), John R. Wingard(6), Paolo Anderlini(6), J. Philip Miller(6), Stephanie J. Lee(5), John P. Klein(5), Michael Haagenson(5)